Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: CpG oligodeoxynucleotide|BIOLOGICAL: HER-2/neu peptide vaccine|BIOLOGICAL: MUC-1 peptide vaccine|BIOLOGICAL: incomplete Freund's adjuvant|BIOLOGICAL: sargramostim|OTHER: immunoenzyme technique|OTHER: immunologic technique
Sponsor: Mayo Clinic
Collaborators: National Cancer Institute (NCI)